UCLA: Attacking metastatic prostate cancer early with combination treatment improves outcomes

As fire encroached, City of Hope prepared to evacuate its Duarte campus

On Jan. 7, a bit after 6 p.m., Ravi Salgia was at his Eaton Canyon home, at the edge of Angeles National Forest.

January 10, 2025

A low omega-6, omega-3 rich diet + fish oil may slow prostate cancer growth, UCLA phase III trial finds

A new phase III trial led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that a diet low in omega-6 and high in omega-3 fatty acids, combined with fish oil supplements, significantly reduced the growth rate of prostate cancer cells in men with early-stage disease.

January 10, 2025

Vol.51 No.01

Clinical Roundup

UCLA: Advanced imaging uncovers hidden metastases in high-risk prostate cancer cases

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

January 10, 2025

Vol.51 No.01

Clinical Roundup

Roswell Park team discovers treatment target for neuroendocrine prostate cancer

A team of researchers at Roswell Park Comprehensive Cancer Center led by Dhyan Chandra has discovered a new therapeutic target for neuroendocrine prostate cancer, a rare and hard-to-treat form of prostate cancer.

January 10, 2025

Vol.51 No.01

In Brief

UCLA’s Christopher Seet receives $2.9M NCI grant to advance cell-based cancer treatments

Christopher Seet received a $2.9 million R37 MERIT Award from NCI to advance the development of innovative T cell therapies for cancer. He is an assistant professor of hematology-oncology at the David Geffen School of Medicine at UCLA.

December 13, 2024

Vol.50 No.46

Clinical Roundup

HIFU demonstrates positive outcomes in management of prostate cancer, study shows

EDAP TMS SA, the global leader in robotic energy-based therapies, announced the publication of the full results from the HIFI study in European Urology, which has the highest impact factor amongst scientific journals focused in urology. The study evaluated high-intensity focused ultrasound versus radical prostatectomy as a first line treatment of localized prostate cancer.

December 13, 2024

Vol.50 No.46

UCLA: Attacking metastatic prostate cancer early with combination treatment improves outcomes

YOU MAY BE INTERESTED IN

As fire encroached, City of Hope prepared to evacuate its Duarte campus

A low omega-6, omega-3 rich diet + fish oil may slow prostate cancer growth, UCLA phase III trial finds

UCLA: Advanced imaging uncovers hidden metastases in high-risk prostate cancer cases

Roswell Park team discovers treatment target for neuroendocrine prostate cancer

UCLA’s Christopher Seet receives $2.9M NCI grant to advance cell-based cancer treatments

HIFU demonstrates positive outcomes in management of prostate cancer, study shows

Renew today!

Subscriber content

Never miss an issue!

Login